Literature DB >> 8409399

Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2.

A Andoh1, Y Fujiyama, T Bamba, S Hosoda.   

Abstract

In the intestinal tract, the local synthesis of C3 and components of both the classical (C4) and alternative (factor B) C activation pathway has previously been demonstrated in vivo. However, the cellular source of this local C synthesis has not been identified. In this study, we demonstrated the syntheses of C3, C4, and factor B in the human colonic adenocarcinoma cell line Caco-2, which is regarded as a good experimental model of normal human intestinal epithelial cells. The results of metabolic labeling experiments indicated that the intra- and extracellular molecular sizes and subunit structures of Caco-2-derived C3, C4, and factor B were compatible with previously reported values for these components in other cells. The functional activities of C3 and C4 in the supernatants were also demonstrated by hemolytic titration assay. Furthermore, C syntheses in this line were independently upregulated by several human cytokines: C3 synthesis was dose-dependently enhanced by the addition of IL-1 beta or TNF-alpha; C4 synthesis was enhanced by the addition of IL-6 or IFN-gamma in the same manner; and the addition of IL-1 beta or IL-6 also induced a dose-dependent increase in factor B synthesis. These enhancing effects were confirmed to be specific for individual cytokines by experiments using anti-human cytokine antibodies. It is likely that intestinal epithelial cells are local production sites of C3, C4, and factor B, and that local C syntheses in the intestine are independently regulated by several cytokines, derived from monocytes/macrophages and T cells resident in the mucosal microenvironment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8409399

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

1.  Cellular localization of complement C3 and C4 transcripts in intestinal specimens from patients with Crohn's disease.

Authors:  J Laufer; R Oren; I Goldberg; A Horwitz; J Kopolovic; Y Chowers; J H Passwell
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

Review 2.  Regulation of epithelial cell functions by the intestinal milieu.

Authors:  Tadao Bamba
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

Review 3.  Do symbiotic bacteria subvert host immunity?

Authors:  Lora V Hooper
Journal:  Nat Rev Microbiol       Date:  2009-05       Impact factor: 60.633

4.  Molecular characterization of complement components (C3, C4, and factor B) in human saliva.

Authors:  A Andoh; Y Fujiyama; T Kimura; H Uchihara; H Sakumoto; H Okabe; T Bamba
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

Review 5.  The intestinal epithelial cell: immunological aspects.

Authors:  A D Christ; R S Blumberg
Journal:  Springer Semin Immunopathol       Date:  1997

6.  Sodium butyrate blocks interferon-gamma (IFN-gamma)-induced biosynthesis of MHC class III gene products (complement C4 and factor B) in human fetal intestinal epithelial cells.

Authors:  K Kitamura; A Andoh; T Inoue; Y Amakata; K Hodohara; Y Fujiyama; T Bamba
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

7.  Counter-regulatory effect of sodium butyrate on tumour necrosis factor-alpha (TNF-alpha)-induced complement C3 and factor B biosynthesis in human intestinal epithelial cells.

Authors:  A Andoh; Y Fujiyama; K Hata; Y Araki; H Takaya; M Shimada; T Bamba
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

8.  Biosynthesis and secretion of MHC class III gene products (complement C4 and factor B) in the exocrine pancreas.

Authors:  K Sumiyoshi; A Andoh; Y Fujiyama; H Sakumoto; T Bamba
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

9.  The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease.

Authors:  T Sugihara; A Kobori; H Imaeda; T Tsujikawa; K Amagase; K Takeuchi; Y Fujiyama; A Andoh
Journal:  Clin Exp Immunol       Date:  2010-01-19       Impact factor: 4.330

10.  The acute phase protein response in patients receiving subcutaneous IL-6.

Authors:  R E Banks; M A Forbes; M Storr; J Higginson; D Thompson; J Raynes; J M Illingworth; T J Perren; P J Selby; J T Whicher
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.